Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 49, Issue 8 (Aug 2011)

Issues

N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda

Henk te Velthuis
  • Sanquin Reagents, Sanquin Blood Supply, Amsterdam, The Netherlands
  • Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, The Netherlands
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ingrid Knop / Peter Stam / Monic van den Broek / Hannie Klaasse Bos
  • Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Suzanne Hol / Elisa Teunissen / Karin Schulte Fischedick / Harald Althaus / Brigitta Schmidt / Carola Wagner / Roel Melsert
Published Online: 2011-06-11 | DOI: https://doi.org/10.1515/CCLM.2011.624

Abstract

Background: High serum concentrations of monoclonal free light chain (FLC) kappa or lambda are markers of plasma cell dyscrasia.

Methods: We developed new, latex-enhanced, specific nephelometric assays based on monoclonal antibodies for the determination of FLC kappa and lambda in serum, EDTA plasma and Li-heparin plasma for use on the Siemens BN™ systems.

Results: Reference ranges were determined from 369 samples: FLC kappa 6.7–22.4 mg/L, FLC lambda 8.3–27.0 mg/L and kappa/lambda ratio 0.31–1.56. Protection from falsely low results due to antigen excess is obtained with a built-in pre-reaction in the assay protocols. Lot-to-lot consistency between three different lots of reagent, calibrators and supplementary reagent lots showed normalized differences <7.5%. The reproducibility of serum samples varied between 4% and 7%. The method comparison with Freelite™ assays showed normalized differences of 19.7%, 32.7% and 21.7%, respectively, for FLC kappa, lambda and ratio, correlations of 0.94, 0.77 and 0.73, and concordance rates of 99.2%, 94.2% and 95%.

Conclusions: N Latex FLC demonstrates high precision, good lot-to-lot consistency and freedom from a high-dose hook effect. The method comparison between Freelite™ and the N Latex FLC assays showed good clinical concordance. Further studies need to reveal the clinical value of the new FLC assays.

About the article

Corresponding author: Dr. Henk te Velthuis, Department of R&D, Sanquin Reagents, Plesmanlaan 125, 1066CX Amsterdam, The Netherlands Phone: +31 20 512 3665, Fax: +31 20 512 3170


Received: 2011-03-03

Accepted: 2011-03-22

Published Online: 2011-06-11

Published in Print: 2011-08-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.624.

Export Citation

©2011 by Walter de Gruyter Berlin Boston. This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Umberto Basile, Francesca Gulli, Laura Gragnani, Cecilia Napodano, Krizia Pocino, Gian Ludovico Rapaccini, Michele Mussap, and Anna Linda Zignego
Journal of Immunological Methods, 2017
[2]
Tadeusz Kubicki, Dominik Dytfeld, Aleksandra Baszczuk, Ewa Wysocka, Mieczysław Komarnicki, and Krzysztof Lewandowski
Postępy Higieny i Medycyny Doświadczalnej, 2017, Volume 71, Number 0, Page 40
[3]
Jennifer L. J. Heaney, John P. Campbell, Anne E. Griffin, Jane Birtwistle, Meena Shemar, J Anthony Child, Walter M. Gregory, David A. Cairns, Gareth Morgan, Graham Jackson, and Mark T. Drayson
British Journal of Haematology, 2017, Volume 178, Number 2, Page 220
[4]
Anne-Sophie Messiaen, Maxime M. W. De Sloovere, Paul-Emile Claus, Martine Vercammen, Lieve Van Hoovels, Olivier Heylen, Johan Debrabandere, Hilde Vanpoucke, and Dieter De Smet
American Journal of Clinical Pathology, 2017, Volume 147, Number 6, Page 611
[6]
Giovanni Cigliana, Francesca Gulli, Cecilia Napodano, Krizia Pocino, Elena De Santis, Luigi Colacicco, Iole Cordone, Laura Conti, and Umberto Basile
Journal of Clinical Laboratory Analysis, 2017, Page e22243
[7]
Supratik Basu, Michael J Wallage, and Robert J Lock
Annals of Clinical Biochemistry, 2013, Volume 50, Number 3, Page 278
[8]
Giuseppe Di Noto, Elena Cimpoies, Alessandra Dossi, Lucia Paolini, Annalisa Radeghieri, Luigi Caimi, and Doris Ricotta
Annals of Clinical Biochemistry, 2015, Volume 52, Number 3, Page 327
[9]
Paolo Milani, Giovanni Palladini, and Giampaolo Merlini
Scandinavian Journal of Clinical and Laboratory Investigation, 2016, Volume 76, Number sup245, Page S113
[10]
Caroline Moreau, Brice Autier, Thibault Cavey, Emmanuel Rouger, James Norwood, Claude Bendavid, Martine Escoffre, Martine Sébillot, and Olivier Decaux
Clinical Lymphoma Myeloma and Leukemia, 2016, Volume 16, Number 12, Page 693
[11]
Colin A Hutchison, Paul Cockwell, and Mark Cook
BMC Clinical Pathology, 2012, Volume 12, Number 1
[12]
Shameem Mahmood, Nancy L. Wassef, Simon J. Salter, Sajitha Sachchithanantham, T. Lane, D. Foard, Carol J. Whelan, Helen J. Lachmann, Julian D. Gillmore, Philip N. Hawkins, and Ashutosh D. Wechalekar
American Journal of Clinical Pathology, 2016, Volume 146, Number 1, Page 78
[13]
S.C. Sasson, K. McGill, L. Wienholt, A. Carr, D.A. Brown, A.D. Kelleher, S.N. Breit, and W.A. Sewell
Pathology, 2015, Volume 47, Number 6, Page 564
[14]
Martijn M. VanDuijn, Joannes F. M. Jacobs, Ron A. Wevers, Udo F. Engelke, Irma Joosten, and Theo M. Luider
Analytical Chemistry, 2015, Volume 87, Number 16, Page 8268
[15]
Antony R. Parker, Oscar Berlanga, and Stephen Harding
BioMed Research International, 2015, Volume 2015, Page 1
[16]
Frank Bridoux, Nelson Leung, Colin A. Hutchison, Guy Touchard, Sanjeev Sethi, Jean-Paul Fermand, Maria M. Picken, Guillermo A. Herrera, Efstathios Kastritis, Giampaolo Merlini, Murielle Roussel, Fernando C. Fervenza, Angela Dispenzieri, Robert A. Kyle, and Samih H. Nasr
Kidney International, 2015, Volume 87, Number 4, Page 698
[17]
Punit Yadav, Nelson Leung, Paul W. Sanders, and Paul Cockwell
Kidney International, 2015, Volume 87, Number 4, Page 692
[18]
Han-Sung Kim, Hyun Soo Kim, Kyu-Sung Shin, Wonkeun Song, Hyo Jung Kim, Hyeong Su Kim, and Min-Jeong Park
BioMed Research International, 2014, Volume 2014, Page 1
[19]
Ellen Jenner
Clinica Chimica Acta, 2014, Volume 427, Page 15
[20]
John P. Campbell, Mark Cobbold, Yanyun Wang, Margaret Goodall, Sarah L. Bonney, Anita Chamba, Jane Birtwistle, Timothy Plant, Zaheer Afzal, Roy Jefferis, and Mark T. Drayson
Journal of Immunological Methods, 2013, Volume 391, Number 1-2, Page 1
[21]
Lola Máiz Suárez, Nuria Garnacho Gayarre, Julia Cabo del Riego, Manuel Penedo Pita, Dolores Formoso Lavandeira, and Ramiro Rueda Rúa
Revista del Laboratorio Clínico, 2013, Volume 6, Number 1, Page 18
[22]
Joannes F.M. Jacobs, Rein M.J. Hoedemakers, Elisa Teunissen, Renate G. van der Molen, and Henk te Velthuis
Clinica Chimica Acta, 2012, Volume 413, Number 19-20, Page 1708
[23]
Rein M.J. Hoedemakers, Johannes F.M. Pruijt, Suzanne Hol, Elisa Teunissen, Henk Martens, Peter Stam, Roel Melsert, and Henk te Velthuis
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 3

Comments (0)

Please log in or register to comment.
Log in